SP 5M 001
Alternative Names: SP-5M-001Latest Information Update: 28 Apr 2024
At a glance
- Originator Shin Poong Pharmaceutical
- Class Adjuvants; Antirheumatics; Eye disorder therapies; Glycosaminoglycans; Urologics
- Mechanism of Action Hyaluronic acid modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Osteoarthritis